|
| |
|
 |
|
|
[DISPLAY PATENT] |
|
|
|
Application no. and date | 04778941.7 (espacenet) (Federated) (European Patent Register), 20040721 | Patent/reg. no. and date | DK/EP 1789433, 20120606 | Publication date | 20070530 | Priority no. and date | US 626037, 20030723 | EP pub. no. and date |
EP 1789433 20070530 | Effective date | | Applicant/owner | Galderma Pharma S.A., World Trade Center Avenue Gratta-Paille 1
1000 Lausanne 30 Grey, CH | Applicant ref. no. | P009788EPDK1 | Inventor | Scherer, Warren J., 2419 Butterfly Palm Dr.
Naples, FL 34119, US | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | Opponent | | IPC Class | A61K 31/498 (2006.01) , A61P 5/24 (2006.01) , C07K 1/00 (2006.01) | Title | Fremgangsmåder til at behandle kutan rødmen med selektive alfa-2-adrenerge receptoragonister | Int. application no. | US2004023649 | Int. publication no. | WO2005010025 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
 |